This site uses cookies to improve your experience. By viewing our content, you are accepting the use of cookies. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country we will assume you are from the United States. View our privacy policy and terms of use.

Remove Cell Based Assays Remove Organic Chemistry Related Topics
Compound Screening Assay Development Cell Biology Bioinformatics Molecular Biology Pharma Companies DNA Pharmacy RNA Small Molecule More Related Topics >
article thumbnail

[Panel Webinar] How to tap into pharma’s $100bn digital transformation opportunity

The Pharma Data

JANUARY 6, 2021

Boehm has a PhD in Organic Chemistry from the University of Nottingham, UK. Dr. Pepe has a PhD in cancer biology and DNA repair and extensive experience in development and validation of cell-based assays. Alessandra Pepe, AD Processes and Infrastructure Manager at Merck Group.

Cell Based Assays 52
Cell Based Assays Compound Screening Organic Chemistry DNA 52
article thumbnail

AI At The Frontier: Empowering Early Career Professionals In Drug Discovery

Elrig

APRIL 29, 2024

After graduating, Miles went on to work as a scientist on AstraZeneca’s Research and Development graduate programme, working on projects in biocatalysis, computational organic chemistry and machine learning for drug discovery.

Bioinformatics 59
Bioinformatics Molecular Biology Drugs Cell Based Assays 59
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

 

Stay Connected

Join 42,000+ Insiders by signing up for our newsletter

About
About
Editions
Editions
Topics
Powered by Aggregage | Terms and Conditions | Your California Rights and Privacy Policy
© Aggregage 2024